CHI Advisors as of Sept. 30, 2019
Portfolio Holdings for CHI Advisors
CHI Advisors holds 13 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Livongo Health | 44.8 | $46M | 2.6M | 17.44 | |
| Orchard Therapeutics Plc ads | 34.6 | $36M | 3.0M | 11.88 | |
| Precision Biosciences Ord | 8.8 | $9.1M | 1.1M | 8.39 | |
| Ovid Therapeutics (OVID) | 2.3 | $2.4M | 727k | 3.24 | |
| Global Blood Therapeutics In | 1.3 | $1.4M | 28k | 48.54 | |
| Blueprint Medicines (BPMC) | 1.3 | $1.3M | 18k | 73.44 | |
| Myokardia | 1.1 | $1.2M | 23k | 52.13 | |
| Corvus Pharmaceuticals (CRVS) | 1.1 | $1.2M | 390k | 3.01 | |
| Unum Therapeutics Ord | 1.1 | $1.1M | 791k | 1.44 | |
| Bluebird Bio | 1.1 | $1.1M | 12k | 91.83 | |
| Ultragenyx Pharmaceutical (RARE) | 1.0 | $1.0M | 24k | 42.79 | |
| Audentes Therapeutics | 1.0 | $983k | 35k | 28.09 | |
| Kezar Life Sciences | 0.5 | $486k | 148k | 3.28 |
